UW and Princeton simulations map fallout scenarios and show Wisconsin at risk. The work arrives after New START expired on Feb. 5, 2026, renewing arms‑control concerns.

Washington University will add the 162‑year‑old St. Louis College of Pharmacy after the 2026‑27 year, keeping the program at the UHSP campus while approvals proceed.

Massachusetts plans to join the GUARDIAN newborn genome‑screening pilot that tests for 450+ treatable genetic conditions. The voluntary program would require state review before enrollment begins.

UC San Diego’s three‑hit model and international analyses link metabolic stress and parental chemical intolerance to autism risk, but experts urge caution. Larger trials are needed.

Raleigh startup Slate Medicines closed a $130M Series A to develop SLTE‑1009, an anti‑PACAP antibody for migraine prevention. The company plans a Phase 1 trial in mid‑2026.

Klaviyo co-founders Ed Hallen and Andrew Bialecki pledged $6 million to MIT’s delta v accelerator, boosting per-team funding and mentorship to help keep startups in Boston.

Livermore‑based Aalyria closed a $100M Series B at about a $1.3B valuation to scale its Spacetime orchestration software and Tightbeam laser terminals. Investors backed the spinout to speed commercial and government deployments.

Denver’s Xcimer says its KrF‑laser prototype could cut electricity costs and create hundreds of local jobs. The company has DOE backing and recent hardware milestones to show investors.

Generate Biomedicines filed to raise up to $425M in a Nasdaq IPO as it advances an AI‑designed antibody into Phase 3 and leans on partnerships with Amgen and Novartis.

A Honolulu summit this week will link startups, allied partners and military sustainment officials to fast track dual use technologies for Indo Pacific resilience.

A 12-story research tower at the University of Miami doubles Sylvester’s research footprint and stacks clinics over labs to speed trials and patient care. The Griffin building adds infusion bays, imaging and AI-driven labs for South Florida.

Missouri Botanical Garden is training AI with hyperspectral, space‑grade scans to identify herbarium specimens. The $14.4M RSI project aims to speed IDs and boost conservation work.

Beth Israel has started offering Clairity Breast, an FDA‑authorized AI that predicts five‑year breast cancer risk from routine mammograms. The tool is available now at BIDMC’s BreastCare Center.